Cargando…
Small-molecule compound from AlphaScreen disrupts tau-glycan interface
Tauopathies are neurodegenerative diseases characterized by intracellular abnormal tau deposits in the brain. Tau aggregates can propagate from one neuron to another in a prion-like manner, mediated by the interaction between tau and cell surface heparan sulfate proteoglycans. We developed an AlphaS...
Autores principales: | Faris, Shannon, Jin, Weihua, Gibson, James, Murray, Anqesha, Smith, Nathan, He, Peng, Zhang, Fuming, Linhardt, Robert, Wang, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798536/ https://www.ncbi.nlm.nih.gov/pubmed/36589242 http://dx.doi.org/10.3389/fmolb.2022.1083225 |
Ejemplares similares
-
Interactions of marine sulfated glycans with antithrombin and platelet factor 4
por: Zhang, Wenjing, et al.
Publicado: (2022) -
The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology
por: Mah, Dylan, et al.
Publicado: (2021) -
Proline-Rich Region II (PRR2) Plays an Important Role in Tau–Glycan Interaction: An NMR Study
por: Murray, Anqesha, et al.
Publicado: (2022) -
Helminth Glycans at the Host-Parasite Interface and Their Potential for Developing Novel Therapeutics
por: Bunte, Myrna J. M., et al.
Publicado: (2022) -
Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants
por: Gelbach, Adrianne L., et al.
Publicado: (2022)